Publication | Closed Access

Syn3 provides high levels of intravesical adenoviral-mediated gene transfer for gene therapy of genetically altered urothelium and superficial bladder cancer

UrologyGenitourinary CancerSuperficial Bladder CancerMedicineHigh LevelsTumor SuppressorCancer GeneticsCancer BiologyCell BiologyCancer ResearchGene Transfer